And c-Rel activity in CD4+ T cells could restrict their anti-tumor responses and promote its differentiation into Tregs and chemical c-Rel inhibition could reduce melanoma growth [55], suggesting c-Rel might harm CD4+ T immune response. The gene discussed is REL; the disease is melanoma.